Effect of Pulsed ACTH add-on Therapy to Weekly Avonex on Remyelination and Neuroregeneration in Patients With Relapsing Remitting Multiple Sclerosis. A 1-year Placebo-controlled, Double-blinded, Randomized Follow-up Study.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2013
At a glance
- Drugs Corticotropin (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Jan 2011 Planned end date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 18 Jan 2011 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.